Final Day Alert! Capillary Technologies IPO GMP Today at 5% as Issue Hits 52% Subscription — Apply or Skip?
Capillary Technologies IPO GMP Today: Capillary Technologies, a leading SaaS-based customer loyalty and engagement solutions provider, is set to tap the primary markets with its ₹877.50 crore Mainboard IPO. The issue is open for subscription but with the Capillary Technologies IPO GMP today slipping to ₹29, investors are asking one question — Is the hype still justified?
Here’s a complete, expert-backed analysis.
What Are the Key Capillary Technologies IPO Details?
The IPO aims to raise ₹877.50 crores through a combination of fresh issue and OFS. Below are the confirmed details:
| Particulars | Details |
|---|---|
| IPO Opening Date | November 14, 2025 |
| IPO Closing Date | November 18, 2025 |
| Issue Size | ₹877.50 crore |
| Price Band | ₹549 – ₹577 per share |
| Market Lot | 25 shares |
| Listing on | BSE & NSE |
| IPO Type | Mainboard |
What Is Capillary Technologies IPO GMP Today?
The Capillary Technologies IPO GMP Today (Gery Market Premium) has shown volatility in recent sessions. As per available data:
| Date | IPO GMP | GMP Trend | Estimated Listing Gain |
|---|---|---|---|
| 18 Nov | ₹29 | GMP Steady | 5.03% |
| 17 Nov | ₹29 | GMP Down | 5.03% |
| 15 Nov | ₹50 | GMP Up | 8.66% |
GMP Insight:
The drop from ₹50 to ₹29 indicates weakening speculative sentiment. However, GMP is not an official indicator and should be treated as market sentiment, not a financial guarantee.
Why Is the GMP Falling — What Are Experts Saying?
Market analysts attribute the GMP decline to:
- Broader market correction in tech and SaaS-heavy counters
- Premium valuation demanded at the upper band
- Moderate subscription expectations from HNIs and retail investors
- Recent weak listings of similar SaaS companies dampening sentiment
Expert Commentary
- Positive View: Analysts who focus on fundamentals argue that Capillary’s strong client stickiness, global presence, and scalable SaaS metrics offer long-term potential.
- Cautious View: Experts warn that the asking valuation is on the higher side, and profitability metrics need strengthening for a high-growth tech company.
Most experts recommend a moderate subscription strategy—apply only if allocation fits your risk tolerance.
Should You Apply for the Capillary Technologies IPO?
✔ Reasons to Apply
- Strong global enterprise client base
- Recurring SaaS revenue model
- Attractive long-term industry (customer loyalty & retention tech)
- Good institutional interest expected
✘ Reasons to Avoid
- GMP trending downward
- Premium valuation vs. industry peers
- Volatility in global tech markets affecting sentiment
Verdict:
If you are a long-term investor, the IPO may be attractive due to strong fundamentals.
If you are applying only for listing gains, the declining GMP is a warning signal — proceed with caution.
How Can You Apply for the Capillary Technologies IPO?
You can apply using:
- UPI-based ASBA through your broker (Zerodha, Groww, Angel One, ICICI Direct, etc.)
- Net banking ASBA (SBI, HDFC Bank, ICICI, Axis, Kotak)
Steps to Apply (UPI):
- Log into your broker app
- Open IPO section → Select Capillary Technologies IPO
- Enter lot size & bid price
- Submit application
- Approve UPI mandate
Capillary Technologies IPO GMP Today FAQs (Frequently Asked Questions)
1. What is the Capillary Technologies IPO GMP today?
The Capillary Technologies IPO GMP today is ₹29.
2. What is the expected listing gain?
As per current GMP, estimated listing gain is 5.03%.
3. What is the lot size for this IPO?
The lot size is 25 shares.
4. Is Capillary Technologies profitable?
The company has shown improving margins, but profitability remains sensitive to global SaaS spending cycles.
5. Should retail investors apply?
Apply only if you have a moderate to high risk appetite or long-term investment horizon.
Click Here to know more market & IPO related news and updates.
Disclaimer: The views and investment insights provided here are based on publicly available information and do not constitute financial advice. Readers are advised to conduct their own research or consult certified financial experts before making investment decisions.
